ORMP
Oramed Pharmaceuticals Inc
$2.33
Earnings Summary
Revenue | $0Mn |
Net Profits | $13.34Mn |
Net Profit Margins | +Inf% |
Highlights
Oramed Pharmaceuticals Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Oramed Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Oramed Pharmaceuticals Inc’s net profit jumped 256.1% since last year same period to $13.34Mn in the Q4 2023. On a quarterly growth basis, Oramed Pharmaceuticals Inc has generated 513.9% jump in its net profits since last 3-months.
Oramed Pharmaceuticals Inc’s net profit margin jumped +Inf% since last year same period to +Inf% in the Q4 2023. On a quarterly growth basis, Oramed Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Oramed Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.02 |
EPS Estimate Current Year | 0.02 |
Highlights
Oramed Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.02 - a 116.67% jump from last quarter’s estimates.
Oramed Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.02.
Key Ratios
Key ratios of the Oramed Pharmaceuticals Inc post its Q1 2024 earnings
Earning Per Share (EPS) | 0.33 |
Highlights
Oramed Pharmaceuticals Inc’s earning per share (EPS) jumped 512.5% since last year same period to 0.33 in the Q1 2024. This indicates that the Oramed Pharmaceuticals Inc has generated 512.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | 0.02 | 0.33 | 1550% |
₹0 US Stocks a/c Opening Fee